Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
J Am Coll Radiol. 2022 Apr;19(4):542-551. doi: 10.1016/j.jacr.2022.01.013. Epub 2022 Mar 2.
Patient experience scores are increasingly important in measuring quality of care and determining reimbursement from payers, including the Hospital Value-Based Purchasing Program and the Radiation Oncology Model. However, the role of bias in patient experience scores in oncology is unknown, raising the possibility that such payment structures may inadvertently perpetuate bias in reimbursement. Therefore, the authors characterized patient-, physician-, and practice-level predictors of patient experience scores in patients undergoing radiation therapy.
The authors retrospectively reviewed patient experience surveys for radiation oncology patients treated at two large multisite academic cancer centers. The outcome was responses on four survey questions. Covariates included self-reported patient demographics, physician characteristics, practice setting characteristics, and wait-time rating linked to each survey. Multivariable ordinal regression models were fitted to identify predictors of receiving a higher score on each of the survey questions.
In total, 2,868 patients completed surveys and were included in the analysis. Patient experience scores were generally high, with >90% of respondents answering 5 of 5 on the four survey items. Physician gender was not associated with any measured patient experience outcomes (P > 0.40 for all). Independent predictors of higher score included a wait-time experience classified as "good" compared with "not good" (q < .001 for all).
Oncology practices aiming to improve patient experience scores may wish to focus their attention on improving wait times for patients. Although a difference in patient experience scores on the basis of physician gender was not observed, such bias is likely to be complex, and further research is needed to characterize its effects.
患者体验评分在衡量医疗质量和确定支付方(包括医院价值采购计划和放射肿瘤学模型)的报销方面变得越来越重要。然而,肿瘤学中患者体验评分的偏差作用尚不清楚,这使得这些支付结构可能无意中加剧了报销中的偏见。因此,作者描述了接受放射治疗的患者的患者、医生和实践水平特征与患者体验评分的关系。
作者回顾性地审查了两家大型多地点学术癌症中心的放射肿瘤学患者的患者体验调查。结果是对四个调查问题的回答。协变量包括患者自我报告的人口统计学特征、医生特征、实践环境特征以及与每个调查相关的等待时间评分。采用多变量有序回归模型来确定每个调查问题上获得更高评分的预测因素。
共有 2868 名患者完成了调查并纳入分析。患者体验评分普遍较高,超过 90%的受访者对四个调查项目中的四项回答了 5 分。医生性别与任何测量的患者体验结果均无关联(所有 P > 0.40)。更高评分的独立预测因素包括将等待时间体验评为“良好”而不是“不佳”(所有 P < 0.001)。
希望提高患者体验评分的肿瘤学实践可能希望将注意力集中在改善患者的等待时间上。虽然没有观察到基于医生性别的患者体验评分存在差异,但这种偏差可能很复杂,需要进一步研究以确定其影响。